Drug intelligence / Profile preview

2C5-QD-Mic

Development stage
Preclinical
Lead developer
Northeastern University
Modality
Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

2C5-QD-Mic is a tumor-targeted near-infrared imaging agent composed of the cancer-specific monoclonal anti-nucleosome antibody 2C5 coupled to quantum dot (QD)-containing polymeric micelles. The micelles are prepared from a polyethylene glycol/phosphatidylethanolamine (PEG-PE) conjugate. This nanocarrier system is designed to enhance the delivery and fluorescence intensity of quantum dots at tumor sites by utilizing the 2C5 antibody's ability to recognize nucleosomes that are frequently exposed on the surface of various cancer cells. In preclinical studies, 2C5-QD-Mic demonstrated a twofold increase in tumor fluorescence compared to non-targeted micelles, suggesting its potential for sensitive optical imaging and detection of tumors with minimal invasiveness.

Other names
2C5-QD-immunomicelles2C5-coupled quantum dot-loaded polymeric micelles2C5-QD-loaded PEG-PE micelles

Beyond the preview

Go deeper on 2C5-QD-Mic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2C5-QD-Mic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call